Browsing by Author Power, Carl A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2006Control of prostate cancer spheroid growth using (213)Bi-labeled multiple targeted alpha radioimmunoconjugates.Allen, Barry; Li, Yong; Madigan, Michele; Apostolidis, Christos; Cozzi, Paul J.; Morgenstern, Alfred; Power, Carl A.; Qu, Chang F.; Rizvi, Syed M. Abbas; Russell, Pamela J.; Wang, Jian; Physics; Medicine; Central Clinical School: Clinical Ophthal & Eye HealthControl of prostate cancer spheroid growth using (213)Bi-labeled multiple targeted alpha radioimmunoconjugates., Prostate, vol.66,(16),2006,pp 1753-1767
2002Experimental models linking dendritic cell lineage, phenotype and functionFazekas De St Groth, Barbara; Smith, Adrian; Sze, Daniel; Austen, Felicity; Bosco, Julian; Power, Carl A.; Central Clinical School: Centenary Institute; Medicine; PharmacyExperimental models linking dendritic cell lineage, phenotype and function, Immunology and Cell Biology, vol.80,(5),2002,pp 469-476
2012In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147Madigan, Michele; Beretov, Julia; Change, Lie; Cozzi, Paul J.; Graham, Peter; Hao, Jingli; Hung, Tzong-Tyng; Kearsley, John H.; Khatri, Aparajita; Li, Yong; Power, Carl A.; Xiao, Weiwei; Central Clinical School: Clinical Ophthal & Eye HealthIn Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147, PLoS One, vol.7, 8, 2012,pp 1-14
2011Monoclonal Antibody Targeting MUC1 and Increasing Sensitivity to Docetaxel as a Novel Strategy in Treating Human Epithelial Ovarian CancerMadigan, Michele; Chen, Hongmin; Hao, Jingli; Li, Yong; Liu, FengHua; O'Brien, P; Patterson, K I; Perkins, Alan C.; Pourgholami, Mohammad H; Power, Carl A.; Wang, Li; Central Clinical School: Clinical Ophthal & Eye HealthMonoclonal Antibody Targeting MUC1 and Increasing Sensitivity to Docetaxel as a Novel Strategy in Treating Human Epithelial Ovarian Cancer, Cancer Letters, vol.300, 2, 2011,pp 122-133